J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Medtech and drug company’s 2025 sales guidance is below consensus
What's Your Reaction?







Chatty News Dec 7, 2024 0 43
Chatty News Nov 18, 2024 0 40
Chatty News Nov 26, 2024 0 35
Chatty News Nov 20, 2024 0 34
Chatty News Dec 26, 2024 0 33
Chatty News Nov 18, 2024 0 21
Chatty News Nov 18, 2024 0 23
Chatty News Nov 18, 2024 0 23
Total Vote: 5
Yes